DEA moves swiftly in issuing final rule placing FYCOMPA in Schedule III drugs
By Delia A. Stubbs & John A. Gilbert – DEA didn’t waste time during its Thanksgiving break. Monday, in just shy of three weeks of the close of its comment period on its proposed rule, DEA issued a final rule placing perampanel in Schedule III. We previously reported on DEA’s delay in issuing a Notice […]